AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CEFTRIAXONE USP
9 registrations across 3 African markets— 6 active
Markets with CEFTRIAXONE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Oframax 1g injection Powder for Injection | 🇿🇲Zambia | Sun Pharmaceutical Industries Limited | active | Dec 2029 |
| SANTRIAX INJECTION | 🇬🇭Ghana | — | active | Jul 2029 |
| SANTRIAX INJECTION | 🇬🇭Ghana | — | active | Jul 2029 |
| Ceftatime -1000 injection Powder for Injection | 🇿🇲Zambia | Mankind Pharma Ltd | active | May 2029 |
| LEXTRIAX 1G INJECTION (Each vial contains Ceftriaxone USP 1g) | 🇬🇭Ghana | — | active | May 2029 |
| LEXTRIAX 1G INJECTION (Each vial contains Ceftriaxone USP 1g) | 🇬🇭Ghana | — | active | May 2029 |
| INFI-AXONE 1G POWDER FOR INJECTION POWDER FOR INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| XONE-250 250MG INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2009 |
| MARIAXONE 1G INJECTION INJECTION | 🇲🇼Malawi | — | expired | Jun 2005 |
CEFTRIAXONE USP in Africa — Regulatory Overview
CEFTRIAXONE USP is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, Malawi, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.